• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2019 Fiscal Year Research-status Report

SMAD-STAT immune signaling network in lung cancer microenvironment

Research Project

Project/Area Number 19K16699
Research InstitutionTokyo Medical University

Principal Investigator

尹 晶煥  東京医科大学, 医学部, 兼任助教 (30748885)

Project Period (FY) 2019-04-01 – 2022-03-31
KeywordsLung cancer / Anti-tumor immunity / Dendritic cell / T cell / TGF-beta / SMADs / STATs
Outline of Annual Research Achievements

<Plan 1: Roles of SMADs in DCs and T cells in lung mucosal immune homeostasis> T cell and DC-specific Smad2 and Smad4 deficient (KO) mice showed normal immune phenotypes. Smad3 KO mice showed deficiency in a DC subset at the steady-state condition.
<Plan 2: Roles of SMADs in DCs and T cells in lung cancer> I have established Lewis lung carcinoma cell line engineered to express GFP or the firefly luciferase gene (luc2) for orthotopic lung cancer model.
<Plan 3: Effects of SMAD deficiency on STAT signaling in DCs and T cells in lung cancer> I have found that increased conventional DCs (cDCs) by SMAD3 deficiency showed significantly enhanced phosphorylation of STAT3.
<Plan 4: Mechanisms how SMAD-STAT signaling networks regulate DCs and T cells in anti-lung cancer immunity> I have generated the various constitutively active or inactive mutants of SMADs or STAT3 using adeno-associated virus system.

Current Status of Research Progress
Current Status of Research Progress

2: Research has progressed on the whole more than it was originally planned.

Reason

As stated in the summary, I have made a progress in accordance with the proposed plans.

Strategy for Future Research Activity

I will continue the research as proposed. I will finish revision of the submitted manuscript to publish the results on the role of SMAD3 on DC development (cf. Plan 1).

Causes of Carryover

Due to the pandemic, I could not spend all the fiscal budget. I will spend the balance for purchasing the antibodies and reagents required for the orthotopic Lewis lung carcinoma model and mechanistic studies this year.

  • Research Products

    (1 results)

All 2019

All Presentation (1 results) (of which Int'l Joint Research: 1 results)

  • [Presentation] SMAD3 Determines Conventional versus Plasmacytoid Dendritic Cell Fates2019

    • Author(s)
      Jeong-Hwan Yoon, Eunjin Bae, Jin Soo Han, Seok Hee Park, Susumu Nakae, InKyu Lee, Ji Hyeon Ju, Isao Matsumoto, Takayuki Sumida and Mizuko Mamura
    • Organizer
      The 48th Annual Meeting of The Japanese Society for Immunology, Hamamatsu, Japan
    • Int'l Joint Research

URL: 

Published: 2021-01-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi